A poor prognosis in human hepatocellular carcinoma is associated with low expression of DPP4

por Yu, Hao, Mei, Xiao-Ping, Su, Peng-Fei, Jin, Guang-Zhi, Zhou, Hong-Kun
Publicado 2020

Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study

por Wang, Wei‐Jun, Liu, Zong‐Han, Wang, Kang, Yu, Hong‐Ming, Cheng, Yu‐Qiang, Xiang, Yan‐Jun, Feng, Jin‐Kai, Zhou, Li‐Ping, Zhou, Hong‐Kun, Pan, Wei‐Wei, Guo, Wei‐Xing, Shi, Jie, Cheng, Shu‐Qun
Publicado 2023

Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK

por PAN, FENG-PING, ZHOU, HONG-KUN, BU, HE-QI, CHEN, ZI-QIANG, ZHANG, HAO, XU, LU-PING, TANG, JIAN, YU, QING-JIANG, CHU, YONG-QUAN, PAN, JIE, FEI, YONG, LIN, SHENG-ZHANG, LIU, DIAN-LEI, CHEN, LIANG
Publicado 2016

Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study

por Wang, Kang, Liu, Zong-Han, Yu, Hong-Ming, Cheng, Yu-Qiang, Xiang, Yan-Jun, Zhong, Jing-Ya, Ni, Qian-Zhi, Zhou, Li-Ping, Liang, Chao, Zhou, Hong-Kun, Pan, Wei-Wei, Guo, Wei-Xing, Shi, Jie, Cheng, Shu-Qun
Publicado 2023

Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A prelim...

por Wang, Kang, Xiang, Yan-Jun, Yu, Hong-Ming, Cheng, Yu-Qiang, Liu, Zong-Han, Zhong, Jing-Ya, Feng, Shuang, Ni, Qian-Zhi, Zhu, Hong-Fei, Pan, Wei-Wei, Li, Jing-Jing, Liang, Chao, Zhou, Hong-Kun, Meng, Yan, Lau, Wan Yee, Cheng, Shu-Qun
Publicado 2023